Free Access
| Issue |
Med Sci (Paris)
Volume 24, Number 4, Avril 2008
|
|
|---|---|---|
| Page(s) | 341 - 343 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2008244341 | |
| Published online | 15 April 2008 | |
- Gordon DJ, Rifkind BM. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med 1989; 321 : 1311–6. [Google Scholar]
- Linsel-Nitschke P, Tall AR. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev 2005; 4 : 193–205. [Google Scholar]
- Ross, R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340 : 115–26. [Google Scholar]
- Cuchel M, Rader DJ. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis. Circulation 2006; 113 : 2548–55. [Google Scholar]
- Oram JF, Lawn RM, Garvin MR, Wade DP. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000; 275 : 34508–11. [Google Scholar]
- Wang N, Lan D, Chen W, et al. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 2004; 101 : 9774–9. [Google Scholar]
- Yvan-Charvet L, Ranalletta M, Wang N, et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest 2007; 117 : 3900–8. [Google Scholar]
- Matsuura F, Wang N, Chen W, et al. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest 2006; 116 : 1435–42. [Google Scholar]
- Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004; 13 : 125–38. [Google Scholar]
- Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 2006; 58 : 342–74. [Google Scholar]
- Morozova S, Suc-Royer I, Auwerx J. Modulateurs du métabolisme du cholestérol et avenir du traitement de l’athérosclérose. Med Sci (Paris) 2004; 20 : 685–90. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.